Corporate news

11.04.2024
Marinomed Biotech AG: Launch of new allergen-blocking Carragelose product in Austria and market entry in Mexico
28.03.2024
Marinomed Biotech AG announces agreement with European Investment Bank (EIB) to defer repayments of the 2019 venture loan for 18 months
26.03.2024
Marinomed Biotech AG enters new Carragelose distribution partnerships for Gulf region and Eastern Europe
01.03.2024
Marinomed Biotech AG: Lucia Ziegler new Head of Investor & Public Relations
Lucia Ziegler, MSc
Head of Investor & Public Relations
Marinomed Biotech AG
Hovengasse 25
2100 Korneuburg, Austria
+43 2262 90300
office@marinomed.com